Carlsmed (NasdaqGS:CARL) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsCaroline Corner - Investor RelationsFelipe Lamar - Senior Equity Research AssociateLeo Greenstein - CFOMichael Cordonnier - CEO and ChairmanTravis Steed - Managing Director in Equity ResearchConference Call ParticipantsJenny Rabinowitz - Global Investment Research AnalystRyan Zimmerman - Managing Director and Senior Equity Research AnalystNone - AnalystOperatorLadies and gentlemen, thank you for standing by, and ...

Carlsmed (NasdaqGS:CARL) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Company ParticipantsCaroline Corner - Investor RelationsFelipe Lamar - Senior Equity Research AssociateLeo Greenstein - CFOMichael Cordonnier - CEO and ChairmanTravis Steed - Managing Director in Equity ResearchConference Call ParticipantsJenny Rabinowitz - Global Investment Research AnalystRyan Zimmerman - Managing Director and Senior Equity Research AnalystNone - AnalystOperatorLadies and gentlemen, thank you for standing by, and ...

Carlsmed (NasdaqGS:CARL) Q4 2025 Earnings call February 25, 2026 04:30 PM ET Speaker5Ladies and gentlemen, thank you for standing by, and welcome to the Carlsmed fourth quarter and full year 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. I would now like to turn the conference over to your first speaker today, Caroline Corner, Investor Relations. Please go ahead, Caroline.Speaker1Thank yo ...

For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Washington, D.C. 20549 l FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Commission File Number 001-42756 CARLSMED, INC. (Exact name of Registrant as specified in its Charter) Delaware 83-1081863 (State or other jurisdiction of inc ...

Fourth quarter revenue of $15.2 million; 61% growth YoY Full year revenue of $50.5 million; 86% growth YoY CARLSBAD, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. "We delivered another very strong quarter with 61% revenue growth year-over-year, gross margin expansion ...

CARLSBAD, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, CEO and Chairman, will be presenting at the 2026 Canaccord Genuity Musculoskeletal Conference on March 2, 2026 at 11:30 AM CST in New Orleans, LA.   A live webcast will be available to registered participants. Following the presentation, the webcast replay will be available at https://event.summitcast.com/view/d69xRqMspwymhwGUDdQoes/JC9qqvWhWggYawxGnDNtmz Abo ...

The corra™ Cervical Plating System marks the debut of Carlsmed's patient-specific fixation portfolioCARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the first personalized cervical plating procedure using the corra™ Cervical Plating System, the latest addition to its portfolio of personalized spine surgery solutions. The procedure, which was performed by Dr. Aaron Clark at the University of California San Francisco (UCSF), repre ...

CARLSBAD, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its fourth quarter and full year 2025 financial results after market close on Wednesday, February 25, 2026. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time. Conference Call Information To participate in this event, dial in approximately 5 to 10 minutes befo ...

CARLSBAD, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced the successful completion of the first posterior lumbar spine surgery using the Company’s aprevo® Lumbar Bi-lateral Posterior System. The procedure was performed by Orthopedic Spine Surgeon CJ Kleck, M.D. at the University of Colorado Hospital in Denver, Colorado. “This clinical milestone strengthens our position as a leader in personalized, data-driven spine solutions designed to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 (State or Other Jurisdiction of Incorporation) Delaware 001-42756 83-1081863 (Commission File Number) (IRS Employer Identification No.) 1800 Aston Ave, Suite 100 Carlsbad, California 92008 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Code: (760) 766-1923 Check the appropriate box below if th ...